Semiconductor materials prepared from bridged bithiazole copolymers

US9570688B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9570688-B2
Application numberUS-201514620755-A
CountryUS
Kind codeB2
Filing dateFeb 12, 2015
Priority dateAug 5, 2010
Publication dateFeb 14, 2017
Grant dateFeb 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides semiconducting compounds, oligomers and polymers of formula wherein A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of The compounds, oligomers and polymers of formula of formula (1) are suitable for use in electronic devices such as organic field effect transistors.

First claim

Opening claim text (preview).

The invention claimed is: 1. An oligomer or polymer of formula wherein A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of wherein R 1 is H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 1 —R 6 , —X 2 —Ar 1 , —X 2 —Ar 2 —Ar 1 , —X 2 —Ar 2 —R 7 or —X 2 —Ar 2 —Ar 3 —R 7 , wherein X 1 at each occurrence is independently —O—, —[Z 1 —O] a —, —[O—Z 1 ] a —O—, —S—, —[Z 1 —S—] a —, [S—Z 1 ] a —S—, —S(O), —C(O)—, —C(O)O—, —C(O)NR 8 —, C(O)S—, —O(CO)—, —S(CO)—, —NR 8 C(O)— or —NR 8 —, wherein Z 1 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, a at each occurrence is independently an integer from 1 to 10 and R 8 at each occurrence is independently H, C 1-20 -alkyl, or —Z 2 —C 6-14 -aryl, wherein Z 2 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, R 6 at each occurrence is independently C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl, X 2 at each occurrence is independently —Z 3 —O—Z 4 —, —Z 3 —S—Z 4 —, —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 9 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 9 C(O)—, —NR 9 —, —Z 3 —SiR 9 2 —Z 4 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond, wherein Z 3 and Z 4 at each occurrence are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and R 9 at each occurrence is independently H, C 1-20 -alkyl, or —Z 5 —C 6-14 -aryl, wherein Z 5 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, Ar 1 at each occurrence is independently C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R a , wherein each R a is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, Ar 2 and Ar 3 at each occurrence are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R b , wherein each R b is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, and R 7 at each occurrence is independently C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -halaolkyl, C 1-20 -alkoxy, —X 3 —Ar 4 , —X 3 —Ar 5 —Ar 4 , —X 3 —Ar 5 —R 10 , or —X 3 —Ar 5 —Ar 6 —R 10 , wherein X 3 at each occurrence is independently —Z 6 —O—Z 7 —, —Z 6 —S—Z 7 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 11 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 11 C(O)—, —NR 11 , —Z 6 —SiR 11 2 —Z 7 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond, wherein Z 6 and Z 7 at each occurrence are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and R 11 at each occurrence is independently H, C 1-20 -alkyl or —Z 8 —C 6-14 -aryl, wherein Z 8 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, Ar 4 at each occurrence is independently C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R c , wherein each R c is independently selected from the group consisting of halogen, CN, —C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, Ar 5 and Ar 6 at each occurrence are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R d , wherein each R d is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, and R 10 at each occurrence is independently C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy, R 3 , R 4 and R 5 can be the same or different and are H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 4 —R 12 , —X 5 —Ar 7 , —X 5 —Ar 8 —Ar 7 , —X 5 —Ar 8 —R 13 or —X 5 —Ar 8 —Ar 9 —R 13 , wherein X 4 at each occurrence is independently —[Z 9 —O] b —, —[Z 9 —S—] b —, —S(O)—, —C(O)—, —C(O)O—, —C(O)NR 14 — or C(O)S—, wherein Z 9 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, b at each occurrence is independently an integer from 1 to 10 and R 14 at each occurrence is independently H, C 1-20 -alkyl, or —Z 10 —C 6-14 -aryl, wherein Z 10 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, R 12 at each occurrence is independently C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl, X 5 at each occurrence is independently —Z 11 —O—Z 12 , —Z 11 —S—Z 12 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 15 , —C(O)S—, —Z 11 —SiR 15 2 —Z 12 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond, wherein Z 11 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, Z 12 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and R 15 at each occurrence is independently H, C 1-20 -alkyl, or —Z 13 —C 6-14 -aryl, wherein Z 13 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 haloalkylene or a covalent bond, Ar 7 at each occurrence is independently C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein each R e is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, Ar 8 and Ar 9 at each occurrence are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein each R f is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl and R 13 at each occurrence is independently C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl, C 1-20 -alkoxy, —X 6 —Ar 10 , —X 6 —Ar 11 —Ar 10 , —X 6 —Ar 11 —R 16 , or —X 6 —Ar 11 —Ar 12 —R 17 , wherein X 6 at each occurance is independently —Z 14 —O—Z 15 —, —Z 14 —S—Z 15 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 18 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 18 C(O)—, —NR 18 —, —Z 14 —SiR 18 2 —Z 15 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond, wherein Z 14 and Z 15 at each occurrence are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and R 18 at each occurrence is independently H, C 1-20 -alkyl or —Z 16 —C 6-14 -aryl, wherein Z 16 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, Ar 10 at each occurrence is independently C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic res

Assignees

Inventors

Classifications

  • Field-effect transistors, e.g. organic thin-film transistors [OTFT] (H10K10/43 takes precedence) · CPC title

  • comprising only sulfur as heteroatom · CPC title

  • H10K85/657Primary

    Polycyclic condensed heteroaromatic hydrocarbons · CPC title

  • Ortho-condensed systems · CPC title

  • Stille reactions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9570688B2 cover?
The present invention provides semiconducting compounds, oligomers and polymers of formula wherein A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of The compounds, oligomers and polymers of formula of formul…
Who is the assignee on this patent?
Basf Se, Polyera Corp
What technology area does this patent fall under?
Primary CPC classification H10K85/657. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).